Some practical considerations for phase III studies with biomarker evaluations.
Novartis Pharmaceuticals, East Hanover, NJ.
Sasikiran
S
Goteti
Samit
S
Hirawat
Cristian
C
Massacesi
Nathalie
N
Fretault
Frank
F
Bretz
Bharani
B
Dharan
D014408:Biomarkers, Tumor / Q000032:analysis*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012107:Research Design
D014408:Biomarkers, Tumor